Mutant but not normal p21 ras elevates inositol phospholipid breakdown in two different cell systems

Area of Science:

• Molecular Biology
• Cell Signaling
• Oncogenesis

Background:

• The p21 ras protein is a key regulator of cellular signaling pathways.
• Mutations in p21 ras are common in human cancers, leading to constitutive activation.
• Inositol phosphate production is a critical second messenger system involved in various cellular processes.

Purpose of the Study:

• To investigate the effect of oncogenic mutant p21 ras on basal inositol phosphate production.
• To determine if the transforming capacity of mutant p21 ras is linked to its effect on inositol phosphate signaling.
• To compare the signaling effects of oncogenic mutant p21 ras with normal p21 ras.

Main Methods:

• Stable transformation of NIH3T3 fibroblasts with oncogenic p21 ras.
• Transient transfection of COS-1 cells with wild-type and mutant p21 ras constructs.
• Measurement of inositol phosphate production rates.

Main Results:

• Expression of oncogenic mutant p21 ras increased basal inositol phosphate production in both NIH3T3 and COS-1 cells.
• Mutations in the effector or carboxy-terminal regions of p21 ras that abolished NIH3T3 transforming capacity also blocked the increase in inositol phosphate production.
• Overexpression of normal (Gly12) p21 ras did not affect basal inositol phosphate production.

Conclusions:

• Constitutively activated p21 ras signaling directly leads to elevated basal inositol phosphate production.
• The transforming ability of oncogenic p21 ras correlates with its impact on this second messenger system.
• These findings highlight a specific signaling consequence of oncogenic p21 ras activation relevant to cancer.